Results 241 to 250 of about 835,318 (379)

OTUD5 Protects Dopaminergic Neurons by Promoting the Degradation of α-Synuclein in Parkinson's Disease Model. [PDF]

open access: yesAdv Sci (Weinh)
Song X   +14 more
europepmc   +1 more source

α-Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease [PDF]

open access: green, 2002
Christophe Lo Bianco   +4 more
openalex   +1 more source

Treatment Selection and Prioritization for the EJS ACT‐PD MAMS Trial Platform

open access: yesMovement Disorders, EarlyView.
Abstract Background There are currently no disease‐modifying therapies (DMTs) registered for Parkinson's disease (PD). The Edmond J. Safra Accelerating Clinical Trials in Parkinson Disease (EJS ACT‐PD) initiative will expedite clinical assessment of putative DMTs through a multi‐arm multistage (MAMS) trial, testing several treatments against a common ...
Cristina Gonzalez‐Robles   +29 more
wiley   +1 more source

Transgenic iPSC Lines with Genetically Encoded MitoTimer to Study Mitochondrial Biogenesis in Dopaminergic Neurons with Tauopathy. [PDF]

open access: yesBiomedicines
Nadtochy JA   +8 more
europepmc   +1 more source

Neuronal α‐Synuclein Disease Stage Progression over 5 Years

open access: yesMovement Disorders, EarlyView.
Abstract Background Neuronal α‐synuclein disease (NSD) is defined by the presence of an in vivo biomarker of neuronal alpha‐synuclein (n‐asyn) pathology. The NSD integrated staging system (NSD‐ISS) for research describes progression across the disease continuum as stages 0 to 6.
Tanya Simuni   +205 more
wiley   +1 more source

Distinct Role for Microglia in Rotenone-Induced Degeneration of Dopaminergic Neurons [PDF]

open access: bronze, 2002
Hui‐Ming Gao   +3 more
openalex   +1 more source

Cholinergic System Changes in Dopa‐Unresponsive Freezing of Gait in Parkinson's Disease

open access: yesMovement Disorders, EarlyView.
Abstract Background Freezing of gait (FoG) is a debilitating mobility disturbance that becomes increasingly resistant to dopaminergic pharmacotherapies with advancing Parkinson's disease (PD). The pathophysiology underlying the response of FoG to dopaminergic treatment is poorly understood.
Kelvin L. Chou   +6 more
wiley   +1 more source

Epigenetic Dynamics in Reprogramming to Dopaminergic Neurons for Parkinson's Disease. [PDF]

open access: yesAdv Sci (Weinh)
Cho B   +7 more
europepmc   +1 more source

Improving the Survival of Grafted Dopaminergic Neurons: A Review over Current Approaches

open access: bronze, 2000
Patrik Brundin   +6 more
openalex   +1 more source

Home - About - Disclaimer - Privacy